Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jul;6(4):657-65.
doi: 10.1038/mi.2013.15. Epub 2013 Apr 3.

Mucosal immunity in human and simian immunodeficiency lentivirus infections

J M Brenchley  1
Affiliations
Review

Mucosal immunity in human and simian immunodeficiency lentivirus infections

J M Brenchley. Mucosal Immunol. 2013 Jul.

Abstract

Overwhelming evidence indicates that distinct pathological phenomenon occurs within the gastrointestinal (GI) tract of progressively simian immunodeficiency virus (SIV)-infected Asian macaques and HIV-infected humans compared with other anatomical sites. Massive loss of GI tract lamina propria CD4 T cells, alteration in the profile of lymphocytic cytokine production, changes in the landscape of GI tract antigen-presenting cells, and variations to the structural barrier of the GI tract are hallmarks of progressive HIV/SIV infections. The pathology within the GI tract results in translocation of microbial products from the lumen of the intestine into peripheral circulation. These translocated microbial products directly stimulate the immune system and exacerbate immune activation and, thus, disease progression. Initiation of combination antiretroviral therapy (cART) does not restore completely the immunological abnormalities within the GI tract. This incomplete restoration within the GI tract may contribute to the increased mortality observed within HIV-infected individuals treated for decades with cART. Novel therapeutic interventions aimed at enhancing GI tract anatomy and physiology may improve the prognosis of HIV-infected individuals.

PubMed Disclaimer

Conflict of interest statement

DISCLOSURE

The author declared no conflict of interest.

References

    1. Giorgi JV, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis. 1999;179:859–870. - PubMed
    1. Salazar-Gonzalez JF, et al. Increased immune activation precedes the inflection point of CD4 Tcells and the increased serum virus load in human immunodeficiency virus infection. J Infect Dis. 1998;178:423–430. - PubMed
    1. Sodora DL, et al. Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat Med. 2009;15:861–865. - PMC - PubMed
    1. Hunt PW, et al. Relationship between Tcell activation and CD4(+) Tcell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. 2008;197:126–133. - PMC - PubMed
    1. Barre-Sinoussi F, et al. Isolation of a T-lympotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science. 1983;220:868–871. - PubMed

Publication types

MeSH terms